INTERFERON alpha2 (IFN alpha2) as anti-angiogenic agent for the treatment of neovascular age-related macular degeneration: a pilot study The aim of this study is to examine the action of Interferon 2 as anti-angiogenic agent for the treatment of neovascular age-related macular degeneration

• Country None
• organs None
• Specialty None

Role of immunosuppression with steroids in the outcome of fibrosis due to recurrent hepatitis C virus (HCV) infection after liver transplantation To assess its histological severity of the fibrosis induced by hepatitis C recurrence after liver transplantation and to correlate it with two different schedules of steroid treatment employed as part...

• Country None
• organs None
• Specialty None

Evaluation of the role of 18F-di-idrossi-fenil-alanina 18F-DOPA in images diagnostic by Positron Emission Tomography PET in study of human neuroendocrin neoplasia - to allow earlier diagnosis of the neural crest derivation neoplasie; - more accurate evaluation of primitive neoplasia extension, of eventual secondary lesions presence and of the therapy answer; ...

• Country None
• organs None
• Specialty None

TOLLERANZA ED EFFICACIA DELL?a-TOCOFEROLO SUCCINATO NEL TRATTAMENTO DI PAZIENTI IN ETA? PEDIATRICA AFFETTI DA EPATITE CRONICA HBsAg POSITIVA efficacia e tollerabilita' del trattamento con vitamina E in bambini affetti da epatite cronica HBsAg./HBeAg positivi

• Country None
• organs None
• Specialty None

Immunosuppression without calcineurin inhibitors and with the use of everolimus (Certican) in HCV-infected liver transplant patients 1. Comparison between study groups of the incidence and severity of histologically-proven rejection episodes. 2. Comparison between study groups of the incidence and severity of histologically-proven ...

• Country None
• organs None
• Specialty None

Use of 68Ga-DOTA-NOC for the evaluation of patients with Idiopathic pulmonary fibrosis STUDY CODE: 68Ga-DOTA-NOC/ILD 01/2008 To evaluate the sensitivity of 68Ga-DOTA-NOC PET/CT for the assessment of Idiopathic Pulmonary Fibrosis patients, in particular IPF and NSIP cases, comparing PET/CT results with data obtained with rou...

• Country None
• organs None
• Specialty None

Plerixafor MM02 - Plerixafor plus G-CSF after chemotherapy for the mobilization of Peripheral Blood Stem Cells (PBSCs) in Multiple Myeloma (MM) patients undergoing Autologous Stem Cell Transplantation (ASCT) Plerixafor in associazione al fattore di crescita granulocitario (G-CSF) dopo chemioterapia per la mobilizzazione di cellule staminali nel sangue periferico (PBSCs) in pazienti con mieloma multiplo (MM) candidati a trapianto di cellule staminali autologhe (ASCT)  Percentage of patients collecting ≥ 6 x 106 CD34+ cells/Kg in three or less apheresis  Percentuale di pazienti in grado di raccogliere ≥ 6 x 106 cellule CD34+ /Kg in tre o meno di tre procedu...

• Country None
• organs None
• Specialty None

OPEN LABEL, PHASE II PILOT STUDY OF STI571 IN THE TREATMENT OF PATIENTS WITH PERIPHERAL T-CELL LYMPHOMA PTCL REFRACTORY, RESISTANT OR NOT AMENABLE TO CONVENTIONAL THERAPY - Assessment of safety and tolerability of imatinib mesylate 400 mg bid in the clinical setting of peripheral T-cell lymphomas PTCL ; - Assessment of clinical responses defined as disease stabiliza...

• Country None
• organs None
• Specialty None

INTRATHECAL LEVOBUPIVACAINE USE IN CESAREAN SECTION : DETERMINATION OF �MINIMUM LOCAL ANESTHETIC DOSE (MLAD)� To detect the most appropriate local anesthetic dose that results in effective subarachnoidal anesthesia in cesarean section , Levobupivacaine, for both surgical purpose and patient`s �comfort anesth...

• Country None
• organs None
• Specialty None

non disponibile

• Country None
• organs None
• Specialty None